Understanding human aging and the fundamental cell signaling link in age-related diseases: the middle-aging hypovascularity hypoxia hypothesis

TJ Phua - Frontiers in aging, 2023 - frontiersin.org
Aging-related hypoxia, oxidative stress, and inflammation pathophysiology are closely
associated with human age-related carcinogenesis and chronic diseases. However, the …

[HTML][HTML] Elucidating the mechanism of traditional Chinese medicine formula (Yifei-sanjie Pill) in alleviating the chemobrain based on network pharmacology and …

Y Wu, H Wang, Z Liang, J Cui, S Liu, Y Chen… - Journal of Traditional …, 2024 - Elsevier
Background Cisplatin (DDP) is widely used to treat clinical malignant tumors, but it is also
accompanied by serious adverse reactions, such as brain nervous system injury. In clinical …

Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

R Gedeborg, F Sandin… - … journal of urology, 2023 - diva-portal.org
BACKGROUND: Randomised controlled trials have demonstrated prolonged survival with
new upfront treatments in addition to standard androgen deprivation therapy (ADT) in men …

Hallmarks of aging: middle-aging hypovascularity, tissue perfusion and nitric oxide perspective on healthspan

TJ Phua - Frontiers in Aging, 2025 - frontiersin.org
Aging is a complex process marked by various changes at both cellular and systemic levels,
impacting the functioning and lifespan of organisms. Over time, researchers have pinpointed …

Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancer

Y Wei, R Zhang, D Zhong, Z Chen, G Chen… - Frontiers in …, 2023 - frontiersin.org
Whether neoadjuvant therapy confers a survival benefit in advanced prostate cancer (PCa)
remains uncertain. The primary endpoints of previous retrospective and phase II clinical …

AI-Powered cellular morphometric biomarkers discovered in needle biopsy of prostatic cancer predict neoadjuvant androgen deprivation therapy response and …

H Yan, AW Mao, D Li, MJ Perez-Baena… - medRxiv, 2024 - medrxiv.org
It is imperative to identify patients with prostate cancer (PCa) who will benefit from androgen
receptor signaling inhibitors that can impact quality of life upon prolonged use. Using our …

Influences on androgen deprivation therapy prescribing before surgery in high‐risk prostate cancer

J Dunsmore, E Duncan, SJ MacLennan… - BJUI …, 2024 - Wiley Online Library
Objectives To understand how best to further reduce the inappropriate use of pre‐surgical
androgen deprivation therapy (ADT), we investigated the determinants (influences) of ADT …

Treatment Strategies for High-Risk Prostate Cancer-Utility of Combination Therapy of Neoadjuvant Therapy and Radical Prostatectomy to Improve Oncologic …

K Nakane, M Kawase, K Iinuma, Y Tobisawa, M Takai… - 2023 - preprints.org
Prostate cancer (PCa) is most commonly observed in male patients. Although PCa
progresses relatively slowly, high-risk PCa is associated with an increased risk of lymph …

[PDF][PDF] Review Not peer-reviewed version

K Nakane, M Kawase, K Iinuma, Y Tobisawa, M Takai… - 2023 - preprints.org
Prostate cancer (PCa) is most commonly observed in male patients. Although PCa
progresses relatively slowly, high-risk PCa is associated with an increased risk of lymph …

[引用][C] The Long and Winding Road from Guideline Recommendations to Improved Quality of Care.

O Bratt - European Urology, 2023 - europepmc.org
The Long and Winding Road from Guideline Recommendations to Improved Quality of Care. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …